GAMMA Investing LLC lifted its position in Welltower Inc. (NYSE:WELL - Free Report) by 17,343.3% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,738,052 shares of the real estate investment trust's stock after purchasing an additional 1,728,088 shares during the period. GAMMA Investing LLC owned about 0.27% of Welltower worth $266,287,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Vestmark Advisory Solutions Inc. lifted its holdings in Welltower by 120.3% in the 4th quarter. Vestmark Advisory Solutions Inc. now owns 14,417 shares of the real estate investment trust's stock worth $1,817,000 after purchasing an additional 7,872 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in Welltower by 30.7% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 544,838 shares of the real estate investment trust's stock worth $68,666,000 after purchasing an additional 128,090 shares in the last quarter. Cbre Investment Management Listed Real Assets LLC lifted its holdings in Welltower by 17.3% in the 4th quarter. Cbre Investment Management Listed Real Assets LLC now owns 1,936,954 shares of the real estate investment trust's stock worth $244,114,000 after purchasing an additional 285,015 shares in the last quarter. Whipplewood Advisors LLC purchased a new position in Welltower in the 4th quarter worth approximately $367,000. Finally, Groupama Asset Managment lifted its holdings in Welltower by 23,204.3% in the 4th quarter. Groupama Asset Managment now owns 1,900,000 shares of the real estate investment trust's stock worth $2,183,000 after purchasing an additional 1,891,847 shares in the last quarter. 94.80% of the stock is owned by hedge funds and other institutional investors.
Welltower Trading Up 0.2%
NYSE:WELL traded up $0.34 during midday trading on Wednesday, hitting $152.54. 848,949 shares of the company traded hands, compared to its average volume of 2,905,046. The firm's fifty day moving average is $148.06 and its 200-day moving average is $141.54. Welltower Inc. has a 12-month low of $100.13 and a 12-month high of $158.55. The firm has a market capitalization of $99.75 billion, a P/E ratio of 97.78, a P/E/G ratio of 2.87 and a beta of 0.94. The company has a current ratio of 4.22, a quick ratio of 4.22 and a debt-to-equity ratio of 0.48.
Welltower (NYSE:WELL - Get Free Report) last released its quarterly earnings results on Monday, April 28th. The real estate investment trust reported $1.20 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.05. Welltower had a return on equity of 3.15% and a net margin of 11.91%. The company had revenue of $2.42 billion for the quarter, compared to analyst estimates of $2.40 billion. During the same quarter in the prior year, the firm posted $1.01 EPS. Welltower's quarterly revenue was up 30.3% compared to the same quarter last year. On average, sell-side analysts predict that Welltower Inc. will post 4.88 EPS for the current year.
Welltower Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Thursday, May 22nd. Investors of record on Wednesday, May 14th were issued a dividend of $0.67 per share. The ex-dividend date was Wednesday, May 14th. This represents a $2.68 annualized dividend and a yield of 1.76%. Welltower's payout ratio is presently 154.02%.
Analysts Set New Price Targets
A number of research analysts recently commented on WELL shares. Evercore ISI boosted their price target on Welltower from $145.00 to $157.00 and gave the stock an "in-line" rating in a report on Thursday, May 1st. Wedbush reiterated an "underperform" rating on shares of Welltower in a research report on Thursday, April 17th. Wall Street Zen downgraded Welltower from a "hold" rating to a "sell" rating in a research report on Thursday, May 8th. Bank of America increased their target price on Welltower from $221.00 to $242.00 and gave the company a "buy" rating in a research report on Tuesday, February 18th. Finally, Scotiabank increased their target price on Welltower from $165.00 to $166.00 and gave the company a "sector outperform" rating in a research report on Thursday, March 6th. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating, nine have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, Welltower presently has a consensus rating of "Moderate Buy" and a consensus target price of $163.25.
Read Our Latest Research Report on Welltower
Welltower Profile
(
Free Report)
Welltower Inc NYSE: WELL, a real estate investment trust ("REIT") and S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. Welltower invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.
Recommended Stories

Before you consider Welltower, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Welltower wasn't on the list.
While Welltower currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.